RENOFYN ApS

RENOFYN ApS (CVR number: 30537335) is a company from NYBORG. The company recorded a gross profit of 15.5 mDKK in 2022. The operating profit was 712.7 kDKK, while net earnings were 476.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was 7.4 %, which can be considered decent but Return on Equity (ROE) was 22.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 22.1 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. RENOFYN ApS's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.